Price (delayed)
$47.43
Market cap
$10.62B
P/E Ratio
128.19
Dividend/share
N/A
EPS
$0.37
Enterprise value
$11.57B
qiagen is the leading global provider of sample to insight solutions to transform biological materials into valuable molecular insights. qiagen sample technologies isolate and process dna, rna and proteins from
There are no recent dividends present for QGEN.
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified. Data from and Sharadar.